0.00
—
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nemaura Medical
Its shares trade under the ticker NMRD. It has been listed since 4 November 2014. In the fiscal year to 31 March 2023, it reported revenue of $77,044 and a net loss of $14.1m. At that date it held total assets of $14.6m and shareholders' equity of −$11.8m.
Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. The company is headquartered in New York City, New York. The company went IPO on 2014-11-04. The Company, through its subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. SugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five-minute intervals via a mobile app. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The Company’s subsidiaries include Region Green Limited.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 4 Nov 2014
- Employees
- 17
- Website
- nemauramedical.com ↗
Leadership
Pay as last reported
- Dr. Dewan ChowdhuryChairman of the Board, President, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, since 2009$338,578
- Dr. Ruhksana QayyumDirector
- Mr. Timothy JohnsonIndependent Director$6,182
- Mr. Thomas MooreIndependent Director$6,182
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 30
- Environment
- 32
- Social
- 36
- Governance
- 21
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nemaura Medical Inc has a strong expertise in developing innovative medical technologies and wearable devices.
- The company's non-invasive continuous glucose monitoring (CGM) technology provides a convenient and pain-free alternative for diabetes patients.
- Nemaura Medical Inc has a diverse portfolio of products that cater to various healthcare needs, enabling them to target a wide range of customer segments.
- The company's partnerships with healthcare providers and research institutions enhance their credibility and provide access to valuable resources and expertise.
Weaknesses
- Nemaura Medical Inc faces intense competition in the medical technology industry, which may challenge their market share and profitability.
- The company relies heavily on regulatory approvals and reimbursement policies, which can be time-consuming and unpredictable, impacting their product launch timelines and financial performance.
- Nemaura Medical Inc's limited brand recognition compared to established players in the industry could make it challenging to penetrate new markets and gain customer trust.
Opportunities
- The increasing prevalence of chronic diseases, such as diabetes, presents a significant growth opportunity for Nemaura Medical Inc's glucose monitoring systems.
- The growing demand for remote patient monitoring and telemedicine solutions creates a favorable market environment for Nemaura Medical Inc's wearable devices and technology.
- Expansion into emerging markets or partnerships with international distributors could help Nemaura Medical Inc tap into new customer bases and increase their global presence.
Threats
- Changes in government regulations and reimbursement policies related to medical devices can pose a significant threat to Nemaura Medical Inc's financial stability and business model.
- The possibility of technological advancements by competitors may diminish the competitive advantage of Nemaura Medical Inc's products and solutions.
- Economic volatility and uncertainty can impact consumer spending on healthcare products, potentially affecting Nemaura Medical Inc's sales and growth.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.